“`html
In a significant development in the field of intellectual property and trade secrets, a U.S. Court of Federal Claims judge has dismissed Vanda Pharmaceuticals’ arguments that certain aspects of its drug’s dissolution metrics constitute a property interest under the Fifth Amendment. This decision marks a notable defeat for the pharmaceutical company in its ongoing legal battle with the federal government over alleged trade secret infringement.
The crux of the case revolves around Vanda’s claim that the governmental disclosure of specific dissolution rates for its medications equated to a constitutional taking of property, as defined in the Fifth Amendment. However, the court determined that these specifications did not meet the criteria necessary to be considered a protected property interest under the Constitution. This ruling is pivotal as it underscores the delineation of what qualifies as a property interest in trade secret disputes involving federal entities.
Those interested in further details of the decision can access the original article through Law360.
“`